Kawajiri H, Kohno T, Kokubo M, Higuchi Y, Shoin S
Jpn J Exp Med. 1985 Dec;55(6):233-7.
Preparations 60F and 50F isolated from the cell-free extract of anticancer hemolytic streptococci possessed not only anticancer activity but hemolytic activity. Thus, the experiment to separate hemolytic substances from 60F and 50F were carried out. Three kinds of fractions were obtained from 60F or 50F by dissolving them in ammonium sulfate solutions of various concentrations. These fractions were named 60F-I, 60F-II and 60F-III, and 50F-I, 50F-II and 50F-III, respectively. 60F-I and 50F-I possessed neither anticancer activity nor hemolytic activity. 60F-II and 50F-II possessed only anticancer activity, and 60F-III and 50F-III possessed only hemolytic activity. Thus, hemolytic substances were separated from 60F and 50F, and it was demonstrated that the anticancer activity of hemolytic streptococci was not due to their hemolysins or hemolytic activity.
从抗癌溶血性链球菌的无细胞提取物中分离出的制剂60F和50F不仅具有抗癌活性,还具有溶血活性。因此,开展了从60F和50F中分离溶血物质的实验。通过将60F或50F溶解于不同浓度的硫酸铵溶液中,得到了三种组分。这些组分分别命名为60F-I、60F-II和60F-III,以及50F-I、50F-II和50F-III。60F-I和50F-I既没有抗癌活性也没有溶血活性。60F-II和50F-II仅具有抗癌活性,而60F-III和50F-III仅具有溶血活性。因此,从60F和50F中分离出了溶血物质,并且证明了溶血性链球菌的抗癌活性并非归因于其溶血素或溶血活性。